Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000936392-95-000156
Filing Date
1995-12-13
Accepted
1995-12-13 00:00:00
Documents
9
Period of Report
1995-09-30
SROs
NASD

Document Format Files

Seq Description Document Type Size
1 LIDAK PHARMACEUTICALS - FORM 10-K ENDED 9/30/95 10-K405 182180
2 CONVERTIBLE NOTE EX-4.9 23294
3 SIXTH AMENDMENT TO SUBLEASE EX-10.13 2387
4 SUBSCRIPTION AGREEMENT EX-10.14 26746
5 NOTE PURCHASE AGREEMENT EX-10.15 27638
6 REGISTRATION RIGHTS AGREEMENT EX-10.16 50482
7 STATEMENT RE COMPUTATION OF NET LOSS PER SHARE EX-11.1 1761
8 INDEPENDENT AUDITORS CONSENT EX-23.1 842
9 FINANCIAL DATA SCHEDULE EX-27.1 2217
  Complete submission text file 0000936392-95-000156.txt   319863
Mailing Address 11077 NORTH TORREY PINES RD LA JOLLA CA 92037
Business Address 11077 NORTH TORREY PINES RD LA JOLLA CA 92037 6195580364
LIDAK PHARMACEUTICALS (Filer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: 10-K405 | Act: 34 | File No.: 000-18734 | Film No.: 95601358
SIC: 2834 Pharmaceutical Preparations